nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—type 2 diabetes mellitus	0.742	1	CbGaD
Tiludronate—PTPN1—brown adipose tissue—type 2 diabetes mellitus	0.0226	0.386	CbGeAlD
Tiludronate—Developmental delay—Pioglitazone—type 2 diabetes mellitus	0.00397	0.0401	CcSEcCtD
Tiludronate—Congenital anomaly—Pioglitazone—type 2 diabetes mellitus	0.00397	0.0401	CcSEcCtD
Tiludronate—PTPN1—nephron tubule—type 2 diabetes mellitus	0.00384	0.0658	CbGeAlD
Tiludronate—PTPN1—cardiovascular system—type 2 diabetes mellitus	0.00345	0.0591	CbGeAlD
Tiludronate—PTPN1—kidney—type 2 diabetes mellitus	0.00338	0.0578	CbGeAlD
Tiludronate—PTPN1—cortex of kidney—type 2 diabetes mellitus	0.00329	0.0563	CbGeAlD
Tiludronate—PTPN1—adipose tissue—type 2 diabetes mellitus	0.00304	0.0521	CbGeAlD
Tiludronate—ATP6V1A—islet of Langerhans—type 2 diabetes mellitus	0.00286	0.049	CbGeAlD
Tiludronate—ATP6V1A—retina—type 2 diabetes mellitus	0.00244	0.0419	CbGeAlD
Tiludronate—ATP6V1A—nephron tubule—type 2 diabetes mellitus	0.0023	0.0394	CbGeAlD
Tiludronate—PTPN1—liver—type 2 diabetes mellitus	0.00213	0.0366	CbGeAlD
Tiludronate—ATP6V1A—kidney—type 2 diabetes mellitus	0.00202	0.0346	CbGeAlD
Tiludronate—ATP6V1A—pancreas—type 2 diabetes mellitus	0.00201	0.0344	CbGeAlD
Tiludronate—ATP6V1A—cortex of kidney—type 2 diabetes mellitus	0.00197	0.0337	CbGeAlD
Tiludronate—ATP6V1A—adipose tissue—type 2 diabetes mellitus	0.00182	0.0312	CbGeAlD
Tiludronate—ATP6V1A—liver—type 2 diabetes mellitus	0.00128	0.0219	CbGeAlD
Tiludronate—Bone pain—Gliclazide—type 2 diabetes mellitus	0.00114	0.0115	CcSEcCtD
Tiludronate—Back pain—Linagliptin—type 2 diabetes mellitus	0.000994	0.01	CcSEcCtD
Tiludronate—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.000959	0.00968	CcSEcCtD
Tiludronate—Vertigo—Tolazamide—type 2 diabetes mellitus	0.000933	0.00942	CcSEcCtD
Tiludronate—Back pain—Nateglinide—type 2 diabetes mellitus	0.000931	0.00939	CcSEcCtD
Tiludronate—Bone pain—Irbesartan—type 2 diabetes mellitus	0.000898	0.00906	CcSEcCtD
Tiludronate—Arthralgia—Linagliptin—type 2 diabetes mellitus	0.000875	0.00883	CcSEcCtD
Tiludronate—Myalgia—Linagliptin—type 2 diabetes mellitus	0.000875	0.00883	CcSEcCtD
Tiludronate—Gastrointestinal pain—Miglitol—type 2 diabetes mellitus	0.000847	0.00855	CcSEcCtD
Tiludronate—Dyspepsia—Tolbutamide—type 2 diabetes mellitus	0.00082	0.00828	CcSEcCtD
Tiludronate—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.000819	0.00827	CcSEcCtD
Tiludronate—Back pain—Repaglinide—type 2 diabetes mellitus	0.000805	0.00813	CcSEcCtD
Tiludronate—Rhinitis—Glipizide—type 2 diabetes mellitus	0.000793	0.00801	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Linagliptin—type 2 diabetes mellitus	0.000764	0.00771	CcSEcCtD
Tiludronate—Back pain—Rosiglitazone—type 2 diabetes mellitus	0.000761	0.00768	CcSEcCtD
Tiludronate—Dyspepsia—Tolazamide—type 2 diabetes mellitus	0.000746	0.00753	CcSEcCtD
Tiludronate—Dyspepsia—Chlorpropamide—type 2 diabetes mellitus	0.000746	0.00753	CcSEcCtD
Tiludronate—Dyspepsia—Acarbose—type 2 diabetes mellitus	0.000717	0.00724	CcSEcCtD
Tiludronate—Arthralgia—Repaglinide—type 2 diabetes mellitus	0.000709	0.00716	CcSEcCtD
Tiludronate—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000709	0.00716	CcSEcCtD
Tiludronate—Dyspepsia—Nateglinide—type 2 diabetes mellitus	0.000691	0.00698	CcSEcCtD
Tiludronate—Arthralgia—Rosiglitazone—type 2 diabetes mellitus	0.00067	0.00676	CcSEcCtD
Tiludronate—Myalgia—Rosiglitazone—type 2 diabetes mellitus	0.00067	0.00676	CcSEcCtD
Tiludronate—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.000668	0.00674	CcSEcCtD
Tiludronate—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.000666	0.00672	CcSEcCtD
Tiludronate—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.000644	0.0065	CcSEcCtD
Tiludronate—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.000642	0.00648	CcSEcCtD
Tiludronate—Back pain—Pioglitazone—type 2 diabetes mellitus	0.000638	0.00644	CcSEcCtD
Tiludronate—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.000621	0.00627	CcSEcCtD
Tiludronate—Back pain—Sitagliptin—type 2 diabetes mellitus	0.00062	0.00626	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Repaglinide—type 2 diabetes mellitus	0.000619	0.00625	CcSEcCtD
Tiludronate—Vertigo—Glipizide—type 2 diabetes mellitus	0.000619	0.00625	CcSEcCtD
Tiludronate—Nausea—Miglitol—type 2 diabetes mellitus	0.000615	0.00621	CcSEcCtD
Tiludronate—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000608	0.00614	CcSEcCtD
Tiludronate—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.000598	0.00604	CcSEcCtD
Tiludronate—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.000593	0.00599	CcSEcCtD
Tiludronate—Myalgia—Glipizide—type 2 diabetes mellitus	0.000586	0.00592	CcSEcCtD
Tiludronate—Arthralgia—Glipizide—type 2 diabetes mellitus	0.000586	0.00592	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.000585	0.00591	CcSEcCtD
Tiludronate—Headache—Tolbutamide—type 2 diabetes mellitus	0.000584	0.00589	CcSEcCtD
Tiludronate—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00058	0.00585	CcSEcCtD
Tiludronate—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.000576	0.00581	CcSEcCtD
Tiludronate—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000574	0.00579	CcSEcCtD
Tiludronate—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000563	0.00569	CcSEcCtD
Tiludronate—Myalgia—Pioglitazone—type 2 diabetes mellitus	0.000562	0.00567	CcSEcCtD
Tiludronate—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.000562	0.00567	CcSEcCtD
Tiludronate—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00056	0.00566	CcSEcCtD
Tiludronate—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00056	0.00566	CcSEcCtD
Tiludronate—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000557	0.00562	CcSEcCtD
Tiludronate—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.000556	0.00561	CcSEcCtD
Tiludronate—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000553	0.00559	CcSEcCtD
Tiludronate—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.000548	0.00553	CcSEcCtD
Tiludronate—Myalgia—Sitagliptin—type 2 diabetes mellitus	0.000546	0.00551	CcSEcCtD
Tiludronate—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.000546	0.00551	CcSEcCtD
Tiludronate—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000537	0.00542	CcSEcCtD
Tiludronate—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000537	0.00542	CcSEcCtD
Tiludronate—Headache—Tolazamide—type 2 diabetes mellitus	0.000531	0.00536	CcSEcCtD
Tiludronate—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000531	0.00536	CcSEcCtD
Tiludronate—Headache—Linagliptin—type 2 diabetes mellitus	0.000525	0.0053	CcSEcCtD
Tiludronate—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.000521	0.00526	CcSEcCtD
Tiludronate—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000519	0.00524	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000512	0.00517	CcSEcCtD
Tiludronate—Rhinitis—Valsartan—type 2 diabetes mellitus	0.000504	0.00509	CcSEcCtD
Tiludronate—Nausea—Tolazamide—type 2 diabetes mellitus	0.000503	0.00508	CcSEcCtD
Tiludronate—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000503	0.00508	CcSEcCtD
Tiludronate—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000495	0.005	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000491	0.00495	CcSEcCtD
Tiludronate—Nausea—Acarbose—type 2 diabetes mellitus	0.000484	0.00488	CcSEcCtD
Tiludronate—Pain—Glipizide—type 2 diabetes mellitus	0.000481	0.00485	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000477	0.00481	CcSEcCtD
Tiludronate—Nausea—Nateglinide—type 2 diabetes mellitus	0.000466	0.00471	CcSEcCtD
Tiludronate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000465	0.00469	CcSEcCtD
Tiludronate—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000462	0.00466	CcSEcCtD
Tiludronate—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000461	0.00465	CcSEcCtD
Tiludronate—Back pain—Gliclazide—type 2 diabetes mellitus	0.00046	0.00465	CcSEcCtD
Tiludronate—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.00046	0.00465	CcSEcCtD
Tiludronate—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00046	0.00464	CcSEcCtD
Tiludronate—Rhinitis—Metformin—type 2 diabetes mellitus	0.000459	0.00463	CcSEcCtD
Tiludronate—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000451	0.00456	CcSEcCtD
Tiludronate—Myalgia—Glyburide—type 2 diabetes mellitus	0.000451	0.00456	CcSEcCtD
Tiludronate—Pain—Sitagliptin—type 2 diabetes mellitus	0.000447	0.00451	CcSEcCtD
Tiludronate—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000444	0.00449	CcSEcCtD
Tiludronate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000439	0.00444	CcSEcCtD
Tiludronate—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000433	0.00437	CcSEcCtD
Tiludronate—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000429	0.00433	CcSEcCtD
Tiludronate—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000428	0.00432	CcSEcCtD
Tiludronate—Headache—Repaglinide—type 2 diabetes mellitus	0.000426	0.0043	CcSEcCtD
Tiludronate—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000425	0.00429	CcSEcCtD
Tiludronate—Back pain—Valsartan—type 2 diabetes mellitus	0.000423	0.00427	CcSEcCtD
Tiludronate—Back pain—Orlistat—type 2 diabetes mellitus	0.000418	0.00422	CcSEcCtD
Tiludronate—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000417	0.00421	CcSEcCtD
Tiludronate—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000415	0.00419	CcSEcCtD
Tiludronate—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000413	0.00417	CcSEcCtD
Tiludronate—Rhinitis—Losartan—type 2 diabetes mellitus	0.000407	0.00411	CcSEcCtD
Tiludronate—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000405	0.00409	CcSEcCtD
Tiludronate—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000405	0.00409	CcSEcCtD
Tiludronate—Nausea—Repaglinide—type 2 diabetes mellitus	0.000404	0.00407	CcSEcCtD
Tiludronate—Asthenia—Glipizide—type 2 diabetes mellitus	0.000403	0.00407	CcSEcCtD
Tiludronate—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000402	0.00406	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000394	0.00398	CcSEcCtD
Tiludronate—Vertigo—Valsartan—type 2 diabetes mellitus	0.000393	0.00397	CcSEcCtD
Tiludronate—Vertigo—Orlistat—type 2 diabetes mellitus	0.000388	0.00392	CcSEcCtD
Tiludronate—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000387	0.00391	CcSEcCtD
Tiludronate—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000386	0.0039	CcSEcCtD
Tiludronate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000385	0.00388	CcSEcCtD
Tiludronate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000381	0.00385	CcSEcCtD
Tiludronate—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000381	0.00385	CcSEcCtD
Tiludronate—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000376	0.0038	CcSEcCtD
Tiludronate—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000375	0.00379	CcSEcCtD
Tiludronate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000374	0.00378	CcSEcCtD
Tiludronate—Myalgia—Valsartan—type 2 diabetes mellitus	0.000372	0.00376	CcSEcCtD
Tiludronate—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000372	0.00376	CcSEcCtD
Tiludronate—Dizziness—Glipizide—type 2 diabetes mellitus	0.000372	0.00375	CcSEcCtD
Tiludronate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000369	0.00372	CcSEcCtD
Tiludronate—Myalgia—Orlistat—type 2 diabetes mellitus	0.000368	0.00371	CcSEcCtD
Tiludronate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000359	0.00362	CcSEcCtD
Tiludronate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000358	0.00361	CcSEcCtD
Tiludronate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000356	0.0036	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000354	0.00357	CcSEcCtD
Tiludronate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000354	0.00357	CcSEcCtD
Tiludronate—Headache—Glipizide—type 2 diabetes mellitus	0.000352	0.00356	CcSEcCtD
Tiludronate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000347	0.0035	CcSEcCtD
Tiludronate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000346	0.00349	CcSEcCtD
Tiludronate—Back pain—Losartan—type 2 diabetes mellitus	0.000342	0.00345	CcSEcCtD
Tiludronate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000342	0.00345	CcSEcCtD
Tiludronate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000342	0.00345	CcSEcCtD
Tiludronate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00034	0.00343	CcSEcCtD
Tiludronate—Myalgia—Metformin—type 2 diabetes mellitus	0.000339	0.00342	CcSEcCtD
Tiludronate—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000338	0.00341	CcSEcCtD
Tiludronate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000337	0.00341	CcSEcCtD
Tiludronate—Nausea—Glipizide—type 2 diabetes mellitus	0.000334	0.00337	CcSEcCtD
Tiludronate—Pain—Gliclazide—type 2 diabetes mellitus	0.000332	0.00335	CcSEcCtD
Tiludronate—Headache—Glimepiride—type 2 diabetes mellitus	0.000329	0.00332	CcSEcCtD
Tiludronate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000328	0.00331	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000325	0.00328	CcSEcCtD
Tiludronate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000324	0.00327	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000321	0.00324	CcSEcCtD
Tiludronate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00032	0.00323	CcSEcCtD
Tiludronate—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00032	0.00323	CcSEcCtD
Tiludronate—Vertigo—Losartan—type 2 diabetes mellitus	0.000318	0.00321	CcSEcCtD
Tiludronate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000318	0.00321	CcSEcCtD
Tiludronate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000314	0.00317	CcSEcCtD
Tiludronate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000313	0.00316	CcSEcCtD
Tiludronate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000312	0.00315	CcSEcCtD
Tiludronate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000311	0.00314	CcSEcCtD
Tiludronate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00031	0.00313	CcSEcCtD
Tiludronate—Asthenia—Glyburide—type 2 diabetes mellitus	0.00031	0.00313	CcSEcCtD
Tiludronate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000307	0.0031	CcSEcCtD
Tiludronate—Pain—Orlistat—type 2 diabetes mellitus	0.000302	0.00305	CcSEcCtD
Tiludronate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000301	0.00304	CcSEcCtD
Tiludronate—Myalgia—Losartan—type 2 diabetes mellitus	0.000301	0.00304	CcSEcCtD
Tiludronate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000297	0.00299	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000296	0.00299	CcSEcCtD
Tiludronate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000296	0.00299	CcSEcCtD
Tiludronate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000292	0.00295	CcSEcCtD
Tiludronate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000288	0.00291	CcSEcCtD
Tiludronate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000286	0.00289	CcSEcCtD
Tiludronate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000282	0.00285	CcSEcCtD
Tiludronate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000281	0.00284	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000279	0.00282	CcSEcCtD
Tiludronate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000279	0.00281	CcSEcCtD
Tiludronate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000279	0.00281	CcSEcCtD
Tiludronate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000273	0.00275	CcSEcCtD
Tiludronate—Headache—Glyburide—type 2 diabetes mellitus	0.000271	0.00274	CcSEcCtD
Tiludronate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00027	0.00273	CcSEcCtD
Tiludronate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000266	0.00268	CcSEcCtD
Tiludronate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000266	0.00268	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000263	0.00266	CcSEcCtD
Tiludronate—Pain—Irbesartan—type 2 diabetes mellitus	0.000262	0.00265	CcSEcCtD
Tiludronate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000258	0.00261	CcSEcCtD
Tiludronate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000258	0.00261	CcSEcCtD
Tiludronate—Nausea—Glyburide—type 2 diabetes mellitus	0.000257	0.00259	CcSEcCtD
Tiludronate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000257	0.00259	CcSEcCtD
Tiludronate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000257	0.00259	CcSEcCtD
Tiludronate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000256	0.00259	CcSEcCtD
Tiludronate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000254	0.00257	CcSEcCtD
Tiludronate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000253	0.00255	CcSEcCtD
Tiludronate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000251	0.00253	CcSEcCtD
Tiludronate—Pain—Losartan—type 2 diabetes mellitus	0.000247	0.00249	CcSEcCtD
Tiludronate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000244	0.00247	CcSEcCtD
Tiludronate—Headache—Gliclazide—type 2 diabetes mellitus	0.000243	0.00246	CcSEcCtD
Tiludronate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000243	0.00245	CcSEcCtD
Tiludronate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000241	0.00244	CcSEcCtD
Tiludronate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000236	0.00238	CcSEcCtD
Tiludronate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000236	0.00238	CcSEcCtD
Tiludronate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000233	0.00235	CcSEcCtD
Tiludronate—Asthenia—Metformin—type 2 diabetes mellitus	0.000233	0.00235	CcSEcCtD
Tiludronate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000231	0.00233	CcSEcCtD
Tiludronate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000228	0.0023	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000226	0.00228	CcSEcCtD
Tiludronate—Headache—Valsartan—type 2 diabetes mellitus	0.000224	0.00226	CcSEcCtD
Tiludronate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000222	0.00225	CcSEcCtD
Tiludronate—Headache—Orlistat—type 2 diabetes mellitus	0.000221	0.00223	CcSEcCtD
Tiludronate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00022	0.00222	CcSEcCtD
Tiludronate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000218	0.0022	CcSEcCtD
Tiludronate—Dizziness—Metformin—type 2 diabetes mellitus	0.000215	0.00217	CcSEcCtD
Tiludronate—Nausea—Valsartan—type 2 diabetes mellitus	0.000212	0.00214	CcSEcCtD
Tiludronate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00021	0.00212	CcSEcCtD
Tiludronate—Nausea—Orlistat—type 2 diabetes mellitus	0.00021	0.00212	CcSEcCtD
Tiludronate—Asthenia—Losartan—type 2 diabetes mellitus	0.000207	0.00209	CcSEcCtD
Tiludronate—Headache—Metformin—type 2 diabetes mellitus	0.000204	0.00206	CcSEcCtD
Tiludronate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000203	0.00205	CcSEcCtD
Tiludronate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000202	0.00204	CcSEcCtD
Tiludronate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000198	0.00199	CcSEcCtD
Tiludronate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000196	0.00198	CcSEcCtD
Tiludronate—Nausea—Metformin—type 2 diabetes mellitus	0.000193	0.00195	CcSEcCtD
Tiludronate—Headache—Irbesartan—type 2 diabetes mellitus	0.000192	0.00194	CcSEcCtD
Tiludronate—Dizziness—Losartan—type 2 diabetes mellitus	0.000191	0.00193	CcSEcCtD
Tiludronate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000182	0.00184	CcSEcCtD
Tiludronate—Headache—Losartan—type 2 diabetes mellitus	0.000181	0.00183	CcSEcCtD
Tiludronate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000178	0.00179	CcSEcCtD
Tiludronate—Nausea—Losartan—type 2 diabetes mellitus	0.000171	0.00173	CcSEcCtD
Tiludronate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000169	0.00171	CcSEcCtD
Tiludronate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000164	0.00165	CcSEcCtD
Tiludronate—Headache—Ramipril—type 2 diabetes mellitus	0.000155	0.00157	CcSEcCtD
Tiludronate—Nausea—Ramipril—type 2 diabetes mellitus	0.000147	0.00148	CcSEcCtD
Tiludronate—ATP6V1A—Disease—GCKR—type 2 diabetes mellitus	0.000117	0.00116	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000113	0.00113	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000113	0.00113	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000113	0.00113	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000113	0.00113	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ALDOB—type 2 diabetes mellitus	0.000112	0.00112	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000111	0.00111	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CD36—type 2 diabetes mellitus	0.000111	0.00111	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—RELA—type 2 diabetes mellitus	0.000111	0.00111	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.00011	0.0011	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PPP2CA—type 2 diabetes mellitus	0.000109	0.00109	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000109	0.00109	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SPRY2—type 2 diabetes mellitus	0.000107	0.00106	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000106	0.00106	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	0.000105	0.00105	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RBP4—type 2 diabetes mellitus	0.000104	0.00104	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000103	0.00103	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000103	0.00103	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	0.000102	0.00102	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MMP1—type 2 diabetes mellitus	0.000101	0.00101	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GIP—type 2 diabetes mellitus	9.94e-05	0.000993	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GIP—type 2 diabetes mellitus	9.94e-05	0.000993	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.89e-05	0.000988	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CALM1—type 2 diabetes mellitus	9.81e-05	0.00098	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SLC2A2—type 2 diabetes mellitus	9.7e-05	0.000968	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—APOA1—type 2 diabetes mellitus	9.67e-05	0.000966	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTR—type 2 diabetes mellitus	9.5e-05	0.000949	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.44e-05	0.000943	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.44e-05	0.000943	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	9.4e-05	0.000939	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NFKB1—type 2 diabetes mellitus	9.34e-05	0.000933	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NAMPT—type 2 diabetes mellitus	9.31e-05	0.00093	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—GCK—type 2 diabetes mellitus	9.26e-05	0.000925	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PRKCB—type 2 diabetes mellitus	9.22e-05	0.000921	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IAPP—type 2 diabetes mellitus	9.2e-05	0.000919	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NOS2—type 2 diabetes mellitus	9.11e-05	0.00091	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SLC9A1—type 2 diabetes mellitus	9.03e-05	0.000902	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.02e-05	0.000901	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.02e-05	0.000901	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PSMD6—type 2 diabetes mellitus	8.99e-05	0.000898	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.92e-05	0.000891	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.78e-05	0.000877	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.78e-05	0.000877	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CYBA—type 2 diabetes mellitus	8.71e-05	0.00087	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HMGA1—type 2 diabetes mellitus	8.47e-05	0.000846	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—AKT1—type 2 diabetes mellitus	8.46e-05	0.000845	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.45e-05	0.000844	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.45e-05	0.000844	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.37e-05	0.000836	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PSMD6—type 2 diabetes mellitus	8.3e-05	0.000829	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SNAP25—type 2 diabetes mellitus	8.3e-05	0.000829	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.16e-05	0.000815	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.16e-05	0.000815	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IGF1—type 2 diabetes mellitus	8.08e-05	0.000807	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT2—type 2 diabetes mellitus	8.08e-05	0.000807	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CYBA—type 2 diabetes mellitus	8.04e-05	0.000803	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CALCA—type 2 diabetes mellitus	7.77e-05	0.000777	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SERPINE1—type 2 diabetes mellitus	7.67e-05	0.000767	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RASGRP1—type 2 diabetes mellitus	7.67e-05	0.000766	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—ALB—type 2 diabetes mellitus	7.66e-05	0.000765	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.53e-05	0.000752	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.53e-05	0.000752	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SLC2A1—type 2 diabetes mellitus	7.51e-05	0.00075	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.46e-05	0.000745	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.46e-05	0.000745	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.46e-05	0.000745	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.46e-05	0.000745	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS1—type 2 diabetes mellitus	7.4e-05	0.000739	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NOS3—type 2 diabetes mellitus	7.33e-05	0.000732	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3R1—type 2 diabetes mellitus	7.33e-05	0.000732	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TCF7L2—type 2 diabetes mellitus	7.32e-05	0.000731	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.27e-05	0.000726	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.27e-05	0.000726	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.27e-05	0.000726	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.27e-05	0.000726	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SLC2A4—type 2 diabetes mellitus	7.2e-05	0.000719	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.15e-05	0.000715	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.15e-05	0.000715	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.63e-05	0.000662	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	6.53e-05	0.000653	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.48e-05	0.000647	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.48e-05	0.000647	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.44e-05	0.000643	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.44e-05	0.000643	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.4e-05	0.00064	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—INSR—type 2 diabetes mellitus	6.4e-05	0.00064	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.29e-05	0.000628	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.29e-05	0.000628	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFBR2—type 2 diabetes mellitus	6.26e-05	0.000626	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.25e-05	0.000625	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.25e-05	0.000625	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN2B—type 2 diabetes mellitus	6.07e-05	0.000606	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AGER—type 2 diabetes mellitus	6.01e-05	0.0006	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ADCY5—type 2 diabetes mellitus	5.99e-05	0.000598	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.99e-05	0.000598	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.99e-05	0.000598	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOB—type 2 diabetes mellitus	5.92e-05	0.000591	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—type 2 diabetes mellitus	5.86e-05	0.000585	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.81e-05	0.000581	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.81e-05	0.000581	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.81e-05	0.000581	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.81e-05	0.000581	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD36—type 2 diabetes mellitus	5.81e-05	0.000581	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PPP2CA—type 2 diabetes mellitus	5.74e-05	0.000573	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.66e-05	0.000565	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.66e-05	0.000565	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—LPL—type 2 diabetes mellitus	5.65e-05	0.000564	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.63e-05	0.000562	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.63e-05	0.000562	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.53e-05	0.000553	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.53e-05	0.000553	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ADCY5—type 2 diabetes mellitus	5.53e-05	0.000552	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.51e-05	0.000551	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.51e-05	0.000551	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.51e-05	0.000551	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.51e-05	0.000551	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—C3—type 2 diabetes mellitus	5.51e-05	0.00055	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.44e-05	0.000544	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.44e-05	0.000544	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SRC—type 2 diabetes mellitus	5.42e-05	0.000541	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PPP2CA—type 2 diabetes mellitus	5.3e-05	0.000529	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—type 2 diabetes mellitus	5.28e-05	0.000527	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—type 2 diabetes mellitus	5.27e-05	0.000527	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRS2—type 2 diabetes mellitus	5.24e-05	0.000523	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CRP—type 2 diabetes mellitus	5.24e-05	0.000523	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CCR5—type 2 diabetes mellitus	5.2e-05	0.00052	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CALM1—type 2 diabetes mellitus	5.15e-05	0.000514	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.13e-05	0.000512	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.13e-05	0.000512	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—type 2 diabetes mellitus	5.09e-05	0.000508	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GCG—type 2 diabetes mellitus	5.04e-05	0.000504	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.04e-05	0.000504	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.04e-05	0.000504	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.96e-05	0.000495	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.96e-05	0.000495	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.94e-05	0.000494	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.94e-05	0.000494	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HIF1A—type 2 diabetes mellitus	4.85e-05	0.000484	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—type 2 diabetes mellitus	4.84e-05	0.000484	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IRS2—type 2 diabetes mellitus	4.84e-05	0.000483	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PRKCB—type 2 diabetes mellitus	4.84e-05	0.000483	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ICAM1—type 2 diabetes mellitus	4.82e-05	0.000481	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CALM1—type 2 diabetes mellitus	4.75e-05	0.000475	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOE—type 2 diabetes mellitus	4.73e-05	0.000473	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOA1—type 2 diabetes mellitus	4.68e-05	0.000468	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRS1—type 2 diabetes mellitus	4.57e-05	0.000457	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS2—type 2 diabetes mellitus	4.41e-05	0.000441	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.39e-05	0.000438	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.39e-05	0.000438	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.34e-05	0.000434	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.34e-05	0.000434	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CASP8—type 2 diabetes mellitus	4.31e-05	0.000431	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AVP—type 2 diabetes mellitus	4.29e-05	0.000428	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.29e-05	0.000428	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.29e-05	0.000428	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.29e-05	0.000428	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.27e-05	0.000426	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.27e-05	0.000426	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.25e-05	0.000424	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.25e-05	0.000424	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT2—type 2 diabetes mellitus	4.23e-05	0.000423	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IRS1—type 2 diabetes mellitus	4.22e-05	0.000422	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOB—type 2 diabetes mellitus	4.14e-05	0.000414	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.14e-05	0.000414	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.13e-05	0.000412	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.13e-05	0.000412	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.08e-05	0.000407	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.08e-05	0.000407	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—INS—type 2 diabetes mellitus	4.04e-05	0.000404	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LPL—type 2 diabetes mellitus	3.96e-05	0.000395	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.96e-05	0.000395	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT2—type 2 diabetes mellitus	3.91e-05	0.000391	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.87e-05	0.000387	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.87e-05	0.000387	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3R1—type 2 diabetes mellitus	3.84e-05	0.000384	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SERPINE1—type 2 diabetes mellitus	3.72e-05	0.000371	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.71e-05	0.000371	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.71e-05	0.000371	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2—type 2 diabetes mellitus	3.7e-05	0.000369	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.64e-05	0.000364	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.64e-05	0.000364	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RELA—type 2 diabetes mellitus	3.62e-05	0.000361	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—C3—type 2 diabetes mellitus	3.56e-05	0.000356	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—C3—type 2 diabetes mellitus	3.56e-05	0.000356	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3R1—type 2 diabetes mellitus	3.55e-05	0.000354	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS3—type 2 diabetes mellitus	3.55e-05	0.000354	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.4e-05	0.000339	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.4e-05	0.000339	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.39e-05	0.000338	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.39e-05	0.000338	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.38e-05	0.000338	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.38e-05	0.000338	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—type 2 diabetes mellitus	3.37e-05	0.000336	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.33e-05	0.000332	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.33e-05	0.000332	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.32e-05	0.000331	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.32e-05	0.000331	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.32e-05	0.000331	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.32e-05	0.000331	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.28e-05	0.000327	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.28e-05	0.000327	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—type 2 diabetes mellitus	3.24e-05	0.000324	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.13e-05	0.000312	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.13e-05	0.000312	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NFKB1—type 2 diabetes mellitus	3.05e-05	0.000305	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.96e-05	0.000295	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.96e-05	0.000295	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—type 2 diabetes mellitus	2.84e-05	0.000284	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.83e-05	0.000283	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—INS—type 2 diabetes mellitus	2.83e-05	0.000283	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.79e-05	0.000278	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.79e-05	0.000278	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.74e-05	0.000274	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.74e-05	0.000274	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.74e-05	0.000273	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.74e-05	0.000273	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SRC—type 2 diabetes mellitus	2.62e-05	0.000262	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.6e-05	0.00026	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.6e-05	0.00026	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—type 2 diabetes mellitus	2.49e-05	0.000249	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.48e-05	0.000248	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.48e-05	0.000248	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.48e-05	0.000248	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.48e-05	0.000248	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—type 2 diabetes mellitus	2.35e-05	0.000234	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.34e-05	0.000234	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.34e-05	0.000234	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—type 2 diabetes mellitus	2.3e-05	0.00023	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.11e-05	0.000211	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.11e-05	0.000211	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.99e-05	0.000199	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.99e-05	0.000199	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.97e-05	0.000197	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.97e-05	0.000197	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—type 2 diabetes mellitus	1.91e-05	0.000191	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.84e-05	0.000184	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.84e-05	0.000184	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.79e-05	0.000179	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.79e-05	0.000179	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—type 2 diabetes mellitus	1.77e-05	0.000177	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—type 2 diabetes mellitus	1.77e-05	0.000176	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.64e-05	0.000164	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.64e-05	0.000164	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—type 2 diabetes mellitus	1.63e-05	0.000163	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.61e-05	0.000161	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.61e-05	0.000161	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.24e-05	0.000124	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.24e-05	0.000124	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.14e-05	0.000114	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.14e-05	0.000114	CbGpPWpGaD
